"Although we were already addressing 80% of the vertebral fracture market with our standard, 5 mm implant, we decided to go a step further by completing the SpineJack® range with two new implants", emphasized Vexim's President and CEO Bruce de la Grange. "This range extension is in line with our strategy of not only covering almost the whole spine but also addressing a global market in which we have to adapt our products to local vertebral morphologies", he added.
Presentation of the two new titanium SpineJack® implants:
- a 6.5 mm diameter model (CE marking in progress, with market launch planned in the coming months) for treating larger vertebrae (lumbar vertebras or other vertebrae in large patients).
- a 4.2 mm diameter model (CE marking in progress, with market launch planned in the coming months) for treating smaller vertebrae (notably thoracic vertebrae or other vertebrae in smaller patients).
About the standard SpineJack® implant
The SpineJack® is a titanium implant (5 mm in diameter and 25 mm in length) that covers 80% of spinal column fractures (vertebrae TH10 to L5). It is inserted into a patient's vertebra via a transpedicular, minimally invasive approach (just one or two 5 mm skin incisions). A simple but specialized set of instruments is used to prepare the vertebra for the X-ray-guided insertion of one or two implants, depending on the anatomical configuration of the fracture and the degree of reconstruction required. Once this step has been completed, bone cement is injected into the restored vertebra in order to secure the vertebral structure and relieve the patient's pain. A trained surgeon needs only 25 to 35 minutes to complete the whole procedure. The patient can expect a very significant reduction in pain immediately after the operation and will generally be discharged from hospital 24 hours later.
About Vexim
Toulouse-based Vexim was founded in February 2006 as a Teknimed spin-off by the well-known entrepreneur Jacques Essinger and the leading European private equity firm Truffle Capital. Vexim is a Med-Tech company that specializes in minimally invasive solutions for the treatment of vertebral fractures. The company was also subsequently financed by Banexi Ventures in September 2006 and received financial support from Oséo (the French state innovation agency) in 2009. Vexim is developing the SpineJack® system for anatomically optimal restorative surgery of vertebral fractures. In July 2009, the company signed an exclusive agreement with Stryker EMEA for distribution of the SpineJack® in Germany, the UK, Austria and Ireland. SpineJack® is CE marked and was first commercialized in mid-2010. The company currently has 23 employees. For more information, visit the company website at www.vexim.fr.
PRESS CONTACTS
Vexim
Bruce de la Grange (President and CEO)
Tel.: +33 (0)6 71 60 23 39
b.delagrange@vexim.fr
Alize RP
Caroline Carmagnol
caroline@alizerp.com // +33 (0)6 64 18 99 59
Anne-Sophie Cosquéric
Anne-Sophie@alizerp.com // +33 (0)1 42 68 86 40
